LAVAL, Quebec, Feb. 13, 2017 /CNW/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today
announced that Joseph C. Papa,
Chairman and CEO, will participate in the following healthcare
conferences:
- 2017 RBC Capital Markets' Healthcare Conference on Thursday, February 23, 2017 at 9:00 a.m. ET at the New York Palace Hotel;
and,
- Barclays Global Healthcare Conference on Wednesday, March 15, 2017 at 8:30 a.m. ET at the Loews Miami Beach Hotel.
A live webcast and audio archive of the events will be available
on Valeant's Investor Relations website and via this URL:
http://ir.valeant.com/events-and-presentations
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, gastrointestinal disorders,
eye health, neurology and branded generics. More information about
Valeant and forward looking statements can be found at
www.valeant.com.
Contact Information:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-participate-at-healthcare-conferences-300405732.html
SOURCE Valeant Pharmaceuticals International, Inc.